Aetiology of Vascular Purpura in a Single Centre Experience: Contribution of Clinical and Paraclinical Data.

aetiology cutaneous leucocytoclastic vasculitis vascular purpura

Journal

Mediterranean journal of rheumatology
ISSN: 2529-198X
Titre abrégé: Mediterr J Rheumatol
Pays: Greece
ID NLM: 101730166

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 28 07 2023
revised: 22 10 2023
accepted: 24 10 2023
medline: 13 5 2024
pubmed: 13 5 2024
entrez: 13 5 2024
Statut: epublish

Résumé

Vascular purpura can be the clinical expression of infectious, inflammatory, drug-related, neoplastic, and endocrine pathologies. To date, there is no consensus codifying the investigation of vascular purpura, especially when it is isolated. We proposed to study through a retrospective study of 73 cases of vascular purpura, occurring during the period 2004-2019 in our internal medicine department, the contribution of various clinical and paraclinical data to the aetiological diagnosis of vascular purpura. Data were considered to be contributory only when they constituted a solid argument in favour of the aetiological diagnosis of vascular purpura. Our series involved 73 patients including 41 women and 32 men (Gender ratio: 0.78). Mean age was 49 ± 17 years [16-80]. Vascular purpura was isolated in 3% of cases. For the remaining patients, it was associated with functional (91%) or physical (48%) manifestations. It was associated with other skin lesions in 45% of cases. The accepted aetiologies were primary vasculitis (26%), drug-related (15%), infectious (11%) and secondary to connectivitis (10%). No cause was found in a third of cases. Clinical data alone made it possible to suggest the aetiology in more than half of cases. Special investigations were contributory in 46% of cases. The course was contributory in 18% of patients for drug-related and paraneoplastic causes. vascular purpura's diverse clinical presentation presents diagnostic challenges. Aetiologies include vasculitis, drug reactions, infections, and connective tissue disorders. Comprehensive clinical assessment is essential.

Sections du résumé

Background UNASSIGNED
Vascular purpura can be the clinical expression of infectious, inflammatory, drug-related, neoplastic, and endocrine pathologies. To date, there is no consensus codifying the investigation of vascular purpura, especially when it is isolated.
Patients and methods UNASSIGNED
We proposed to study through a retrospective study of 73 cases of vascular purpura, occurring during the period 2004-2019 in our internal medicine department, the contribution of various clinical and paraclinical data to the aetiological diagnosis of vascular purpura. Data were considered to be contributory only when they constituted a solid argument in favour of the aetiological diagnosis of vascular purpura.
Results UNASSIGNED
Our series involved 73 patients including 41 women and 32 men (Gender ratio: 0.78). Mean age was 49 ± 17 years [16-80]. Vascular purpura was isolated in 3% of cases. For the remaining patients, it was associated with functional (91%) or physical (48%) manifestations. It was associated with other skin lesions in 45% of cases. The accepted aetiologies were primary vasculitis (26%), drug-related (15%), infectious (11%) and secondary to connectivitis (10%). No cause was found in a third of cases. Clinical data alone made it possible to suggest the aetiology in more than half of cases. Special investigations were contributory in 46% of cases. The course was contributory in 18% of patients for drug-related and paraneoplastic causes.
Conclusion UNASSIGNED
vascular purpura's diverse clinical presentation presents diagnostic challenges. Aetiologies include vasculitis, drug reactions, infections, and connective tissue disorders. Comprehensive clinical assessment is essential.

Identifiants

pubmed: 38736952
doi: 10.31138/mjr.280723.aov
pii: MJR-35-1-94
pmc: PMC11082763
doi:

Types de publication

Journal Article

Langues

eng

Pagination

94-107

Informations de copyright

© 2024 The Mediterranean Journal of Rheumatology (MJR).

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Auteurs

Amira El Ouni (A)

CHU Mongi Slim, La Marsa, Tunisia.

Faiza Ben Messaoud (F)

CHU Mongi Slim, La Marsa, Tunisia.

Rym Khayati (R)

CHU Mongi Slim, La Marsa, Tunisia.

C Abdelkafi (C)

CHU Mongi Slim, La Marsa, Tunisia.

Zeineb Meddeb (Z)

CHU Mongi Slim, La Marsa, Tunisia.

Saloua Hamzaoui (S)

CHU Mongi Slim, La Marsa, Tunisia.

Thara Larbi (T)

CHU Mongi Slim, La Marsa, Tunisia.

Sana Toujani (S)

CHU Mongi Slim, La Marsa, Tunisia.

Kamel Bouslama (K)

CHU Mongi Slim, La Marsa, Tunisia.

Classifications MeSH